Literature DB >> 34409731

Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells.

Louis Devlin1,2, Joshua Okletey1, George Perkins2, Jonathan R Bowen1, Konstantinos Nakos1, Cristina Montagna3, Elias T Spiliotis1.   

Abstract

Septins are a family of multimeric GTP-binding proteins, which are abnormally expressed in cancer. Septin 9 (SEPT9) is an essential and ubiquitously expressed septin with multiple isoforms, which have differential expression patterns and effects in breast cancer cells. It is unknown, however, if SEPT9 isoforms associate with different molecular networks and functions. Here, we performed a proteomic screen in MCF-7 breast cancer cells to identify the interactome of GFP-SEPT9 isoforms 1, 4 and 5, which vary significantly in their N-terminal extensions. While all three isoforms associated with SEPT2 and SEPT7, the truncated SEPT9_i4 and SEPT9_i5 interacted with septins of the SEPT6 group more promiscuously than SEPT9_i1, which bound predominately SEPT8. Spatial mapping and functional clustering of non-septin partners showed isoform-specific differences in interactions with proteins of distinct subcellular organelles (e.g., nuclei, centrosomes, cilia) and functions such as cell signalling and ubiquitination. The interactome of the full length SEPT9_i1 was more enriched in cytoskeletal regulators, while the truncated SEPT9_i4 and SEPT9_i5 exhibited preferential and isoform-specific interactions with nuclear, signalling, and ubiquitinating proteins. These data provide evidence for isoform-specific interactions, which arise from truncations in the N-terminal extensions of SEPT9, and point to novel roles in the pathogenesis of breast cancer.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  SEPT9 isoforms; breast cancer; septin interactome; septin proteomics; septins

Mesh:

Substances:

Year:  2021        PMID: 34409731      PMCID: PMC8612247          DOI: 10.1002/pmic.202100155

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   5.393


  122 in total

1.  Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue.

Authors:  Diana Connolly; Hien G Hoang; Esther Adler; Cagdas Tazearslan; Nichelle Simmons; Vahni Vishala Bernard; Maria Castaldi; Maja H Oktay; Cristina Montagna
Journal:  Biol Chem       Date:  2014-02       Impact factor: 3.915

Review 2.  Septin genomics: a road less travelled.

Authors:  S E Hilary Russell; Peter A Hall
Journal:  Biol Chem       Date:  2011-08-02       Impact factor: 3.915

3.  Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors.

Authors:  S E Russell; M A McIlhatton; J F Burrows; P G Donaghy; S Chanduloy; E M Petty; L M Kalikin; S W Church; S McIlroy; D P Harkin; G W Keilty; A N Cranston; J Weissenbach; I Hickey; P G Johnston
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

4.  Proteomic mapping by rapamycin-dependent targeting of APEX2 identifies binding partners of VAPB at the inner nuclear membrane.

Authors:  Christina James; Marret Müller; Martin W Goldberg; Christof Lenz; Henning Urlaub; Ralph H Kehlenbach
Journal:  J Biol Chem       Date:  2019-09-13       Impact factor: 5.157

5.  Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.

Authors:  Namrata D Udeshi; Tanya Svinkina; Philipp Mertins; Eric Kuhn; D R Mani; Jana W Qiao; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2012-12-24       Impact factor: 5.911

6.  The nucleoporin ELYS/Mel28 regulates nuclear envelope subdomain formation in HeLa cells.

Authors:  Michaela Clever; Tomoko Funakoshi; Yasuhiro Mimura; Masatoshi Takagi; Naoko Imamoto
Journal:  Nucleus       Date:  2012-03-01       Impact factor: 4.197

Review 7.  Cellular functions of actin- and microtubule-associated septins.

Authors:  Elias T Spiliotis; Konstantinos Nakos
Journal:  Curr Biol       Date:  2021-05-24       Impact factor: 10.900

8.  High SEPT9_i1 protein expression is associated with high-grade prostate cancers.

Authors:  Roni Gilad; Karen Meir; Ilan Stein; Larissa German; Eli Pikarsky; Nicola J Mabjeesh
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

9.  Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.

Authors:  Chao Gao; Shu-Guang Liu; Wen-Ting Lu; Zhi-Xia Yue; Xiao-Xi Zhao; Tian-Yu Xing; Zhen-Ping Chen; Hu-Yong Zheng; Zhi-Gang Li
Journal:  Mol Med Rep       Date:  2020-07-17       Impact factor: 2.952

10.  Cell type-specific expression of SEPT3-homology subgroup members controls the subunit number of heteromeric septin complexes.

Authors:  Mikael E Sellin; Sonja Stenmark; Martin Gullberg
Journal:  Mol Biol Cell       Date:  2014-03-19       Impact factor: 4.138

View more
  2 in total

Review 1.  Spatial regulation of microtubule-dependent transport by septin GTPases.

Authors:  Elias T Spiliotis; Ilona A Kesisova
Journal:  Trends Cell Biol       Date:  2021-07-09       Impact factor: 20.808

2.  ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma.

Authors:  Congcong Zhang; Jiangtao Cui; Leiqun Cao; Xiaoting Tian; Yayou Miao; Yikun Wang; Shiyu Qiu; Wanxin Guo; Lifang Ma; Jinjing Xia; Xiao Zhang
Journal:  J Cell Mol Med       Date:  2022-09-07       Impact factor: 5.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.